SCHEMBL29331870

SCHEMBL29331870

C#Cc1c(-c2ccc(OC)c(OC)c2)cc(-c2ccc(F)cc2)nc1N

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.64
▸ TDP1 Q9NUW8 1/20 0.64
▸ MEN1 O00255 4/20 0.63
▸ KMT2A Q03164 4/20 0.63
▸ ALDH1A1 P00352 3/20 0.63
▸ GLA P06280 2/20 0.63
▸ GAA P10253 2/20 0.63
▸ MAPT P10636 2/20 0.63
▸ L3MBTL1 Q9Y468 2/20 0.63
▸ GFER P55789 1/20 0.63
▸ ADORA2A P29274 4/20 0.62
▸ ADORA1 P30542 4/20 0.62
▸ SLC10A2 Q12908 1/20 0.56
▸ IL4 P05112 1/20 0.49
▸ HSP90AA1 P07900 1/20 0.48
▸ HSP90AB1 P08238 1/20 0.48
▸ BLM P54132 1/20 0.46
▸ SQOR Q9Y6N5 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ PKM P14618 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23841107 0.88 KDM4E (0.82) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL29331857 0.79 IL4 (0.77) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL31139657 0.78 KDM4E (1.00) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL7505116 0.77 KDM4E (0.84) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL31139650 0.76 KDM4E (0.81) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL29332196 0.72 TNKS (0.43) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL7553240 0.72 KDM4E (0.76) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL3371543 0.70 ADORA1 (0.89) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL7510328 0.69 KDM4E (0.71) KDM4ETDP1MEN1KMT2AALDH1A1
SCHEMBL7509621 0.69 KDM4E (0.71) KDM4ETDP1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043621-B2 Small molecule inhibitors of Interleukin-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2024-07-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043621-B2 Small molecule inhibitors of Interleukin-4 IL4, IL2, IL4I1 KDM4E 586/4885TDP1 4759/4885MEN1 3952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback